Test shown to improve accuracy in identifying precancerous pancreatic cysts
In a proof-of-concept study, an international scientific team led by Johns Hopkins Kimmel Cancer Center…
Browsing: Pancreatic Cancer
New research gives hope in the fight against pancreatic cancer
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO Pancreatic ductal adenocarcinoma (PDAC), the most common…
Long thought harmless, a glycan biomarker may cause pancreatic disease and cancer
A widely recognised biomarker for pancreatic disease, CA19-9, thought to be benign for decades, may…
ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer
The randomised, phase III POLO trial found that maintenance therapy with the PARP inhibitor olaparib…
Pancreatic cancer specialist explains challenges of the disease and treatment advances
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…
Key protein a possible new target in the treatment of pancreatic cancer
Advanced pancreatic cancer is often symptomless, leading to late diagnosis only after metastases have spread…
Researchers succeed at removing some types of pancreatic cancer in animal models
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer…
AACR 2019: PARP inhibitors can shrink tumours in pancreatic cancer patients with specific mutations
Switching pancreatic cancer patients to the PARP inhibitor rucaparib as maintenance therapy instead of continuing…
AACR 2019: Excess body weight before 50 is associated with higher risk of dying from pancreatic cancer
Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk…
AACR 2019: CD40 combination therapy can shrink pancreatic tumours
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumours to shrink in…